Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
CD2-C52H5 | Cynomolgus | Cynomolgus CD2 / SRBC Protein, His Tag | ![]() |
![]() ![]() |
|
CD2-H82E6 | Human | Biotinylated Human CD2 / SRBC Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
|
CD2-H5258 | Human | Human CD2 / SRBC Protein, Fc Tag | ![]() |
![]() ![]() |
|
CD2-H5226 | Human | Human CD2 / SRBC Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
Loaded Human CD2, Fc Tag (Cat. No. CD2-H5258) on Protein A Biosensor, can bind Human CD58, His Tag (Cat. No. LF3-H5225) with an affinity constant of 2.3 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Rejection of renal transplantation; Diabetes Mellitus, Type 1; Leukemia; Renal Insufficiency; Rejection of liver transplantation; Neoplasms; Myelodysplastic Syndromes; Kidney Diseases; Graft vs Host Disease; Multiple Myeloma; Psoriasis; Lymphoma, T-Cell; Hidradenitis Suppurativa; Lymphoma; Anemia, Sickle Cell; Kidney Failure, Chronic | Details |
Alefacept | LFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485 | Phase 1 Clinical | Astellas Pharma Inc | Diabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma | Details |
SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute | Details |
Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Rejection of renal transplantation; Diabetes Mellitus, Type 1; Leukemia; Renal Insufficiency; Rejection of liver transplantation; Neoplasms; Myelodysplastic Syndromes; Kidney Diseases; Graft vs Host Disease; Multiple Myeloma; Psoriasis; Lymphoma, T-Cell; Hidradenitis Suppurativa; Lymphoma; Anemia, Sickle Cell; Kidney Failure, Chronic | Details |
Alefacept | LFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485 | Phase 1 Clinical | Astellas Pharma Inc | Diabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma | Details |
SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute | Details |
This web search service is supported by Google Inc.